Walley Alexander Y, Cheng Debbie M, Quinn Emily K, Blokhina Elena, Gnatienko Natalia, Chaisson Christine E, Krupitsky Evgeny, Coffin Philip O, Samet Jeffrey H
Department of Medicine, Section of General Internal Medicine, Clinical Addiction Research and Education Unit, Boston University School of Medicine & Boston Medical Center, 801 Massachusetts Avenue, Boston, USA.
Department of Biostatistics, Boston University School of Public Health, 801 Massachusetts Avenue, Boston, USA.
Int J Drug Policy. 2017 Jan;39:114-120. doi: 10.1016/j.drugpo.2016.10.022. Epub 2016 Nov 28.
Among Russians living with HIV/AIDS who inject drugs, we examined the incidence of fatal and non-fatal overdoses following discharge from a narcology hospital and the associations with more advanced HIV infection.
Prospective cohort study of data collected at baseline, 3 and 6 months from HIV-infected patients with a history of injection drug use who were not treated with anti-retroviral therapy. Participants were recruited between 2012-2014 from a narcology (addiction) hospital in St. Petersburg, Russia.
Fatal overdose was determined based on contact reports to study staff in the year after discharge. Non-fatal overdose was self-reported at the 3- and 6-month assessments. The main independent variable for HIV severity was CD4 cell count at the baseline interview (<200cells/mm≥200cells/mm). Secondary analyses assessed time since HIV diagnosis and treated with anti-retroviral treatment (ART) prior to enrolment as independent variables. We fit Cox proportional hazards models to assess whether HIV severity is associated with either fatal or non-fatal overdose.
Among 349 narcology patients, 18 participants died from overdose within one year after discharge (8.7%, 95% CI 3.4-14.2 by Kaplan-Meier); an estimated 51% [95% CI 34-68%] reported at least one non-fatal overdose within 6 months of discharge. HIV severity, time since HIV diagnosis and ever ART were not significantly associated with either fatal or non-fatal overdose events.
Fatal and non-fatal overdose are common among Russians living with HIV/AIDS who inject drugs after narcology hospital discharge. Overdose prevention interventions are urgently warranted among Russian narcology patients with HIV infection.
在俄罗斯感染艾滋病毒/艾滋病的注射吸毒者中,我们研究了戒毒医院出院后致命和非致命药物过量的发生率,以及与更晚期艾滋病毒感染的关联。
对未接受抗逆转录病毒治疗、有注射吸毒史的艾滋病毒感染患者在基线、3个月和6个月时收集的数据进行前瞻性队列研究。参与者于2012年至2014年期间从俄罗斯圣彼得堡的一家戒毒(成瘾)医院招募。
致命药物过量根据出院后一年内与研究人员的接触报告确定。非致命药物过量在3个月和6个月评估时自我报告。艾滋病毒严重程度的主要自变量是基线访谈时的CD4细胞计数(<200个细胞/mm³或≥200个细胞/mm³)。二次分析将艾滋病毒诊断后的时间以及入组前接受抗逆转录病毒治疗(ART)的情况作为自变量进行评估。我们拟合Cox比例风险模型,以评估艾滋病毒严重程度是否与致命或非致命药物过量相关。
在349名戒毒患者中,18名参与者在出院后一年内死于药物过量(8.7%,卡普兰-迈耶法估计95%置信区间为3.4 - 14.2%);估计51%[95%置信区间34 - 68%]的参与者报告在出院后6个月内至少有一次非致命药物过量。艾滋病毒严重程度、艾滋病毒诊断后的时间以及是否接受过抗逆转录病毒治疗均与致命或非致命药物过量事件无显著关联。
在俄罗斯感染艾滋病毒/艾滋病的注射吸毒者中,戒毒医院出院后致命和非致命药物过量情况常见。对于感染艾滋病毒的俄罗斯戒毒患者,迫切需要采取药物过量预防干预措施。